Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q39705730> ?p ?o ?g. }

Showing items 1 to 100 of ±119 with 100 items per page.

Q39705730 description "2016 nî lūn-bûn" @default.
Q39705730 description "2016年の論文" @default.
Q39705730 description "2016年学术文章" @default.
Q39705730 description "2016年学术文章" @default.
Q39705730 description "2016年学术文章" @default.
Q39705730 description "2016年学术文章" @default.
Q39705730 description "2016年学术文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016年學術文章" @default.
Q39705730 description "2016년 논문" @default.
Q39705730 description "article científic" @default.
Q39705730 description "article scientific" @default.
Q39705730 description "article scientifique (publié 2016)" @default.
Q39705730 description "articol științific" @default.
Q39705730 description "articolo scientifico" @default.
Q39705730 description "artigo científico (publicado na 2016)" @default.
Q39705730 description "artigo científico (publicado na 2016)" @default.
Q39705730 description "artigo científico" @default.
Q39705730 description "artikull shkencor" @default.
Q39705730 description "artikulong pang-agham" @default.
Q39705730 description "artykuł naukowy" @default.
Q39705730 description "artículo científico publicado en 2016" @default.
Q39705730 description "artículu científicu espublizáu en 2016" @default.
Q39705730 description "bilimsel makale" @default.
Q39705730 description "bài báo khoa học" @default.
Q39705730 description "mokslinis straipsnis" @default.
Q39705730 description "naučni članak" @default.
Q39705730 description "scienca artikolo" @default.
Q39705730 description "scientific article" @default.
Q39705730 description "teaduslik artikkel" @default.
Q39705730 description "tieteellinen artikkeli" @default.
Q39705730 description "tudományos cikk" @default.
Q39705730 description "vedecký článok" @default.
Q39705730 description "vetenskaplig artikel" @default.
Q39705730 description "videnskabelig artikel (udgivet 2016)" @default.
Q39705730 description "vitenskapelig artikkel" @default.
Q39705730 description "vitskapeleg artikkel" @default.
Q39705730 description "vědecký článek" @default.
Q39705730 description "wetenschappelijk artikel" @default.
Q39705730 description "wissenschaftlicher Artikel" @default.
Q39705730 description "επιστημονικό άρθρο" @default.
Q39705730 description "мақолаи илмӣ" @default.
Q39705730 description "мақолаи илмӣ" @default.
Q39705730 description "наукова стаття, опублікована в червні 2016" @default.
Q39705730 description "научна статия" @default.
Q39705730 description "научная статья" @default.
Q39705730 description "научни чланак" @default.
Q39705730 description "научни чланак" @default.
Q39705730 description "գիտական հոդված" @default.
Q39705730 description "מאמר מדעי" @default.
Q39705730 description "سائنسی مضمون" @default.
Q39705730 description "مقالة علمية نشرت بتاريخ 4-6-2016" @default.
Q39705730 description "مقالهٔ علمی" @default.
Q39705730 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
Q39705730 description "บทความทางวิทยาศาสตร์" @default.
Q39705730 description "სამეცნიერო სტატია" @default.
Q39705730 name "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 name "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 type Item @default.
Q39705730 label "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 label "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 prefLabel "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 prefLabel "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 P1433 Q39705730-F6D49795-C474-4C77-BAE1-911DCC3B08EF @default.
Q39705730 P1476 Q39705730-5A13E17B-FBA1-4C26-97A4-4C220A50F429 @default.
Q39705730 P2093 Q39705730-0D1DDC0D-5B05-45E8-9170-AB7EC32DB625 @default.
Q39705730 P2093 Q39705730-157CB795-F63C-4219-9AB5-F9E6ED30E917 @default.
Q39705730 P2093 Q39705730-4EAD76C2-3A5C-46C7-A03C-CD6C58FCF5F5 @default.
Q39705730 P2093 Q39705730-71774C93-220C-4092-B96B-EDF12211A2DD @default.
Q39705730 P2093 Q39705730-793563AD-F357-4B5F-9875-718F2C8757EA @default.
Q39705730 P2093 Q39705730-8D83E8A5-7EC7-4F3F-B263-1A5E0E64B77F @default.
Q39705730 P2093 Q39705730-BD169E26-9540-45B0-B648-6348E2776703 @default.
Q39705730 P2093 Q39705730-E32F8F48-96E8-469B-AE15-12F42F1C9FA3 @default.
Q39705730 P2093 Q39705730-EB2E145F-A6A1-4A51-B7DA-08DD71FC8BDE @default.
Q39705730 P2093 Q39705730-FD4CA224-C702-43A2-A22A-3DA46C7C2FDC @default.
Q39705730 P304 Q39705730-A7265E8F-BF16-4FAD-88CB-FDAC3E0AF520 @default.
Q39705730 P31 Q39705730-B315E0B6-F4A6-4B13-BF9B-FA210A36291C @default.
Q39705730 P356 Q39705730-348900C0-1D62-4A59-8F75-5C3914770BD8 @default.
Q39705730 P407 Q39705730-AA1549AC-403B-42E4-BC30-7D58BEC0EA86 @default.
Q39705730 P433 Q39705730-CA846AEA-8234-4FDC-9EF5-1D288810BC1B @default.
Q39705730 P478 Q39705730-D12358F0-6034-4228-9A2B-EEDBE135FB1C @default.
Q39705730 P50 Q39705730-57C0F538-28FE-4958-9AFA-4C3F4DA45602 @default.
Q39705730 P50 Q39705730-DA8D36F7-9B9D-4106-A9B6-69D06F549266 @default.
Q39705730 P577 Q39705730-B160355E-DD99-4CAC-8B0B-E6BF77AF7F1E @default.
Q39705730 P698 Q39705730-13A48D41-A675-4ABB-B667-DDAFB7650C55 @default.
Q39705730 P921 Q39705730-56A4673E-C0C0-40C4-98E5-B5EAFF16C811 @default.
Q39705730 P921 Q39705730-7B69AE57-A7D5-446F-971F-B40F1137AE73 @default.
Q39705730 P921 Q39705730-AA8E9E62-1936-4FEF-830A-F398A9E4DC97 @default.
Q39705730 P356 J.JAAD.2016.04.054 @default.
Q39705730 P698 27268421 @default.
Q39705730 P1433 Q15757046 @default.
Q39705730 P1476 "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)." @default.
Q39705730 P2093 "Abhijit Gadkari" @default.
Q39705730 P2093 "E Rand Sutherland" @default.
Q39705730 P2093 "Eric L Simpson" @default.
Q39705730 P2093 "Gianluca Pirozzi" @default.